Cerevel Therapeutics Holdings, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
40.82
|
|
Average Rating
|
4.42
|
|
# Strong Buys
|
7
|
|
# Buys
|
3
|
|
# Holds
|
2
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.62
|
-0.66
|
-0.04
|
-6.45%
|
|
2022-06-30
|
-0.48
|
-0.62
|
-0.14
|
-29.17%
|
|
2022-03-31
|
-0.42
|
-0.46
|
-0.04
|
-9.52%
|
|
2021-12-31
|
-0.41
|
-0.40
|
0.01
|
2.44%
|
|
2021-09-30
|
-0.40
|
-0.43
|
-0.03
|
-7.50%
|
|
2021-06-30
|
-0.39
|
-0.42
|
-0.03
|
-7.69%
|
|
2021-03-31
|
-0.41
|
-0.40
|
0.01
|
2.44%
|
|
2020-12-31
|
-0.45
|
-0.27
|
0.18
|
40.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.74
|
|
2021-12-31
|
-1.65
|
|
2020-12-31
|
-5.77
|